Novelix Pharmaceuticals Ltd Share Price

Pharmaceuticals

BSE: 536565 Small Cap ISIN: INE314I01036

As on 18 July 2026 at 22:53 IST

₹81.15

+ 1.67

(2.10%)

Sell Buy

Over 1 Month

44.88%

Over 6 Months

29.81%

Over 1 Year

170.99%

Over 3 Years

665.70%

Novelix Pharmaceuticals Ltd Summary

Close ₹79.48

Open ₹76.60

High ₹81

Low ₹70

Volume 38,890

Net Turnover (in Cr) ₹0.29

52Wk High ₹81.60

52Wk Low ₹29.33

52Wk High / Low

29.33

81.60

Novelix Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹189.92

EPS (TTM) 1.07

Book Value (BV) 21.81

Div. Yield -

P/E (TTM) 74.28

Price/Book Value 3.64

Delivery % 70.23 %

Face Value 10

Key Ratios

PE Ratio 332.63

PB Ratio 1.51

EV to Sales 0.84

PEG Ratio 0.48

ROA 0.46

ROE 0.56

Debt-Equity -

Net Profit Margin 0.26

Operating Profit Margin 0.52

Novelix Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Total Revenue	9.16	9.59	10.85	10.84	10.71
Total Expenses	11.23	10.35	11.06	10.96	10.91
Profit Before Tax	-2.03	-3.75	-0.21	-0.12	-0.21
Profit After Tax	-2.03	-3.76	-0.26	-0.15	-0.35
Operating Profit After Depreciation	-2.12	-3.73	-0.21	-0.12	-0.20

Balance Sheet

Particulars (in ₹ Cr.)	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Fixed Assets	0.47	1.65	1.83	1.92	2.17
Total Non Current Assets	2.81	2.24	2.33	2.62	3.02
Total Current Assets	5.93	7.33	11.39	10.72	10.56
Total Assets	8.74	9.57	13.72	13.34	13.58
Total Shareholder's Fund	7.40	6.86	10.60	10.92	11.17

Cash Flow

Particulars (in ₹ Cr.)	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Net Cash From Operating Activities	1.59	1.59	0.63	-0.53	0.37
Net Cash Used In Investing Activities	-0.76	0.14	0.45	0.43	-0.64
Net Cash Used In Financing Activities	-	-0.77	-0.16	-0.05	0.02

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	30.73	4.53	1.92	1.39	1.31
Total Expenses	30.61	4.51	1.98	2.96	4.58
Profit Before Tax	0.12	0.02	-0.06	-1.57	-3.27
Profit After Tax	0.08	0.01	-0.06	-1.56	-3.27
Operating Profit After Depreciation	0.12	0.02	-0.06	-1.57	-3.27

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0.19	0.12	0.17	0.23	0.22
Total Non Current Assets	0.27	3.24	3.01	2.62	4.07
Total Current Assets	26.93	4.13	4.24	4.63	4.70
Total Assets	27.21	7.36	7.26	7.25	8.77
Total Shareholder's Fund	17.54	7.35	7.20	7.24	8.80

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-13.68	-0.34	-2.41	0.59	0.58
Net Cash Used In Investing Activities	2.93	0.19	0.08	0.28	0.21
Net Cash Used In Financing Activities	11.32	-	-	-	-

Particulars (in ₹ Cr.)	2022-09	2022-06	2022-03	2021-12	2021-09
Total Revenue	1.24	1.36	0.69	1.11	2.46
Total Expenses	1.43	1.50	2.32	2.09	2.31
Profit Before Tax	-0.15	-0.08	-1.48	-0.95	0.44
Profit After Tax	-0.15	-0.09	-1.57	-0.74	0.35
Operating Profit after Depreciation	-0.13	-0.06	-1.51	-0.91	0.48

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	25.19	48.40	36.36	22.35	20.86
Total Expenses	23.91	47.09	35.66	22.17	20.63
Profit Before Tax	1.23	1.28	0.72	0.17	0.21
Profit After Tax	0.91	1	0.53	0.11	0.18
Operating Profit after Depreciation	1.28	1.31	0.73	0.18	0.23

Novelix Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 72.65

S2 65.83

S3 61.65

Pivot 76.83

R1 83.65

R2 87.83

R3 94.65

Moving Average

20 SMA 59.17

50 SMA 56.73

100 SMA 57.39

200 SMA 53.87

Novelix Pharmaceuticals Ltd Corporate Actions

No available data

AGM Date: 27 Sep 2021

In terms of Regulations of SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 as amended we are forwarding the notice of 27th Annual General Meeting of the Company which is being dispatched to our Shareholders on 2nd September 2021. The 27th Annual General meeting of the Company is scheduled to be held on Monday 27th day of September 2021 through Video Conferencing (VC) / Other Audio Visual Means. Outcome of 27th AGM held on Monday, 27.09.2021 at 11:00 A.M. Scrutinizer Report of the 27th AGM held on 27.09.2021 27Th Annual General Meeting Of The Company Held On Monday, 27.09.2021 At 11.00 A.M. Through Video Conference (As per BSE Announcement dated on 27.09.2021) This is to inform that the Register of Members and the Share transfer books of the Company will remain closed from 21st September, 2021 to 27th September, 2021 (both days inclusive) for the purpose of Annual General Meeting which is scheduled to be held on 27th September, 2021 at 11:00 a.m. through Video Conference/Other Audio Visual Means. Further 20th September, 2021 is fixed as cut-off date for e-voting in connection with the 27th Annual General Meeting of the Company. Trimurthi Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 28.09.2021)

AGM Date: 19 Aug 2022

Outcome of the Board Meeting A.G.M (Book Closure Revised) (As Per BSE Bulletin dated on 29.07.2022) Annual report (As Per BSE Announcement dated on 28.07.2022) Book closure for the purpose of Annual General Meeting (As Per BSE Announcement dated on 29.07.2022) Trimurthi Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 20.08.2022)

AGM Date: 15 Sep 2023

paper ad for notice of AGM Book Closure for the purpose of AGM (As Per BSE Announcement Dated on 23/08/2023) Annual general Meeting for FY 2022-23 held on 15.09.2023 (As Per BSE Announcement Dated on 15/09/2023)

AGM Date: 27 Sep 2024

Annual General Meeting for FY 2023-24 is scheduled to be held on Friday, 27' day of September 2024 at 11:30 a.m. through video conference/ other Audio Visual means. outcome of AGM held on 27.09.2024 (As Per BSE Announcement Dated on: 27/09/2024)

AGM Date: 19 Sep 2025

Submission of Intimation of Book Closure for the purpose of AGM. Submission of Notice of 31st AGM (As Per BSE Announcement Dated on:26.08.2025)

EGM Date: 25 Feb 2022

EGM 25/02/2022 Notice of 1/2021-22 Extra-Ordinary General Meeting ('EGM') to be held on 25.02.2022 (As Per BSE Announcement Dated on 29/01/2022) Outcome of 1/2021-22 EGM held on Friday, 25.02.2022 at 11:00 A.M. Scrutinizer Report of the 1/2021-22 EGM held on 25.02.2022 1/2021-22 Extra-Ordinary General Meeting Of The Company Held On Friday, 25.02.2022 At 11.00 A.M. Through Video Conference Trimurthi Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 25/02/2022)

EGM Date: 27 Dec 2022

EGM 27/12/2022 Outcome of the Extra Ordinary General Meeting held on 27th December 2022 at 10:00 a.m. (As Per BSE Announcement dated on 27.12.2022) update on shareholders meeting (As Per BSE Announcement Dated on 09/01/2023)

EGM Date: 18 Nov 2024

An Extra Ordinary General Meeting of the Company to be convened on Monday, 18' November, 2024 4:00P.M., through Video Conferencing/ Other Audio Visual Means (OAVM) in compliance with the applicable provisions of the Companies Act. 2013 read with MCA General Circular No. 14/2020 dated 08.04.2020, General Circular No. 17/2020 dated 13.04.2020, General Circular No. 222020 dated 15.06.2020. General Circular No. 33/2020 dated 28.09.2020, General Circular No, 39/2020 dated 31.12.2020. General Circular No.10/2021dated 23.06.2021, General Circular No. 20/2021 dated 08.12.2021, General Circular No. 32022 dated 05.05.2022, General Circular No. 10/2022 dated 28.12.2022, General Circular No. 11/2022 dated 28.12.2022, General Circular No. 09/2023 dated 25.09.2023 and General Circular No. 09/2024 dated 19.09.2024 to transact the above business. Outcome and Summary Proceedings of the EGM held on Monday, November 18, 2024 at 4:00 P.M. via VC (As per BSE Announcement Dated on 18/11/2024)

EGM Date: 09 May 2025

Submission of outcome of Board Meeting held on 12th April, 2025 Submission of Notice of EGM of the members of the Company to be held on 09th May, 2025. Submission of intimation of cut off date & e-voting period. Submission of voting results along with scrutinizers report. Submission of outcome of EGM held on 09th May, 2025. (As Per BSE Announcement Dated on :10.05.2025) Intimation of confirmation of appointment of directors. (As Per BSE Announcement Dated on :11.05.2025) Submission of revised proceedings of the EGM held on 09th May, 2025. (As Per BSE Announcement Dated on 14.05.2025)

EGM Date: 01 Jan 2026

EGM 01/01/2026

EGM Date: 09 Jan 2026

Submission of Intimation of EGM, cut-off date and Remote e-voting. Submission of Notice of Extra Ordinary General Meeting. (As Per BSE Announcement Dated on:15.12.2025) Submission of Intimation of Outcome of EGM held on 09th January, 2026. (As per BSE Announcement dated on: 09.01.2026) Submission of Voting Results along with Scrutinizer''s report. Submission of Confirmation of Appointment as Director. (As per BSE Announcement dated on: 10.01.2026)

Novelix Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Novelix Pharmaceuticals Ltd Top Mutal Funds Invested

No data available

Novelix Pharmaceuticals Ltd News

Novelix Pharmaceuticals EGM scheduled

On 1 July 2026

06 Jun 2026, 01:40 pm

Novelix Pharma inks pact with German Firm to boost Astaxanthin output

Novelix Pharmaceuticals entered into an agreement with GMBU e.V., Halle (Saale), Germany, to scale up the production of Astaxanthin at the company's research facilities in Hyderabad.

03 Jun 2026, 04:23 pm

Novelix Pharmaceuticals to convene board meeting

On 4 June 2026

02 Jun 2026, 03:24 pm

Novelix Pharmaceuticals to announce Quarterly Result

On 29 May 2026

27 May 2026, 08:53 am

Novelix Pharmaceuticals board approves allotment of 23.20 lakh equity shares

At meeting held on 12 February 2026

13 Feb 2026, 10:22 am

Novelix Pharmaceuticals Ltd Stock Analysis

Annual revenue for Novelix Pharmaceuticals Ltd increased by 578.29% to ₹30.73 crore in FY 2025 from ₹4.53 crore in FY 2024.
Annual Net Profit for Novelix Pharmaceuticals Ltd increased by 711.76% to ₹0.08 crore in FY 2025 from ₹0.01 crore in FY 2024.
Promoter Shareholding in Novelix Pharmaceuticals Ltd increased by 2.29% in the most recent quarter, from 49.43% in March 2026 to 50.57% in June 2026.
Novelix Pharmaceuticals Ltd delivered a 1-year return of 170.99% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Novelix Pharmaceuticals Ltd share price moved up by 2.10% from its previous close of INR ₹79.48. The latest Novelix Pharmaceuticals Ltd share price is INR ₹81.15.
Novelix Pharmaceuticals Ltd share price today has been at a low of 80.40 and a high of 84.70. Over the past 52 weeks, the Novelix Pharmaceuticals Ltd share price has seen a low of 29.33 and a high of 84.70.